Nierenberg, Tori C.
Thomas, Samantha M.
Halliday, Ian
Botty van den Bruele, Astrid
Chiba, Akiko
Modell Parrish, Kendra J.
Woriax, Hannah E.
DiNome, Maggie L.
Westbrook, Kelly E.
Plichta, Jennifer K. https://orcid.org/0000-0002-7411-0558
Funding for this research was provided by:
NIH (P30CA014236, K12AR084231)
Article History
Received: 24 March 2025
Accepted: 1 May 2025
First Online: 11 May 2025
Declarations
:
: The authors report no proprietary or commercial interest in any product mentioned or concept discussed in this article. Dr. J. Plichta is a recipient of research funding by the Color Foundation (PI: Plichta). JP is a member of Editorial Committee for the American Joint Committee on Cancer (AJCC), the Breast Panel for the AJCC, and the National Comprehensive Cancer Network (NCCN) Breast Cancer Diagnosis and Screening panel. S. Thomas is a member of the Evidence-Based Medicine Core, the Breast Panel, and the Neuroendocrine Tumors Panel for the AJCC. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
: This study was approved by our institutional review board, and given the use of de-identified data, a waiver of consent was granted.
: This study was approved by our institutional review board, and given the use of de-identified data, a waiver of consent was granted.
: Not applicable.